File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1034/j.1601-0825.2002.01818.x
- Scopus: eid_2-s2.0-0036021296
- PMID: 12206401
- WOS: WOS:000176662500005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole
Title | Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole |
---|---|
Authors | |
Keywords | Antifungals Candida Lactoferrin Lysozyme |
Issue Date | 2002 |
Publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1354-523X&site=1 |
Citation | Oral Diseases, 2002, v. 8 n. 4, p. 199-206 How to Cite? |
Abstract | OBJECTIVE: To assess the antifungal activity of lysozyme and lactoferrin on 10 oral isolates each of Candida albicans and Candida tropicalis following their brief exposure (1 h) to subtherapeutic concentrations of two polyene drugs - nystatin, amphotericin B, and an azole -fluconazole. METHODS: Yeasts were sequentially exposed to sub-therapeutic concentrations of antifungals and then to either lysozyme or lactoferrin and the viability evaluated by quantifying colony-forming units. RESULTS: The exposure of both C. albicans and C. tropicalis isolates to all three antifungal agents significantly increased their susceptibility to lysozyme (P < 0.05) but not to lactoferrin. Exposure to the two polyene drugs had a lesser impact on the lysozyme susceptibility of both Candida species compared with the azole drug. Both interspecies and intraspecies sensitivity to lysozyme was noted and C. albicans was less susceptible than C. tropicalis. CONCLUSIONS: Lysozyme, in addition to being a potent natural antifungal agent, may act synergistically with the studied antimycotics. |
Persistent Identifier | http://hdl.handle.net/10722/66763 |
ISSN | 2023 Impact Factor: 2.9 2023 SCImago Journal Rankings: 0.895 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Anil, S | en_HK |
dc.contributor.author | Samaranayake, LP | en_HK |
dc.date.accessioned | 2010-09-06T05:49:08Z | - |
dc.date.available | 2010-09-06T05:49:08Z | - |
dc.date.issued | 2002 | en_HK |
dc.identifier.citation | Oral Diseases, 2002, v. 8 n. 4, p. 199-206 | en_HK |
dc.identifier.issn | 1354-523X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/66763 | - |
dc.description.abstract | OBJECTIVE: To assess the antifungal activity of lysozyme and lactoferrin on 10 oral isolates each of Candida albicans and Candida tropicalis following their brief exposure (1 h) to subtherapeutic concentrations of two polyene drugs - nystatin, amphotericin B, and an azole -fluconazole. METHODS: Yeasts were sequentially exposed to sub-therapeutic concentrations of antifungals and then to either lysozyme or lactoferrin and the viability evaluated by quantifying colony-forming units. RESULTS: The exposure of both C. albicans and C. tropicalis isolates to all three antifungal agents significantly increased their susceptibility to lysozyme (P < 0.05) but not to lactoferrin. Exposure to the two polyene drugs had a lesser impact on the lysozyme susceptibility of both Candida species compared with the azole drug. Both interspecies and intraspecies sensitivity to lysozyme was noted and C. albicans was less susceptible than C. tropicalis. CONCLUSIONS: Lysozyme, in addition to being a potent natural antifungal agent, may act synergistically with the studied antimycotics. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1354-523X&site=1 | en_HK |
dc.relation.ispartof | Oral Diseases | en_HK |
dc.subject | Antifungals | - |
dc.subject | Candida | - |
dc.subject | Lactoferrin | - |
dc.subject | Lysozyme | - |
dc.subject.mesh | Amphotericin B - administration & dosage - therapeutic use | en_HK |
dc.subject.mesh | Analysis of Variance | en_HK |
dc.subject.mesh | Anti-Infective Agents - therapeutic use | en_HK |
dc.subject.mesh | Antifungal Agents - administration & dosage - therapeutic use | en_HK |
dc.subject.mesh | Candida albicans - drug effects | en_HK |
dc.subject.mesh | Candida tropicalis - drug effects | en_HK |
dc.subject.mesh | Colony Count, Microbial | en_HK |
dc.subject.mesh | Fluconazole - administration & dosage - therapeutic use | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Lactoferrin - therapeutic use | en_HK |
dc.subject.mesh | Microbial Sensitivity Tests | en_HK |
dc.subject.mesh | Mouth - microbiology | en_HK |
dc.subject.mesh | Muramidase - therapeutic use | en_HK |
dc.subject.mesh | Nystatin - administration & dosage - therapeutic use | en_HK |
dc.subject.mesh | Species Specificity | en_HK |
dc.subject.mesh | Statistics as Topic | en_HK |
dc.title | Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1354-523X&volume=8&spage=199&epage=206&date=2002&atitle=Impact+of+lysozyme+and+lactoferrin+on+oral+Candida+isolates+exposed+to+polyene+antimycotics+and+fluconazole | en_HK |
dc.identifier.email | Samaranayake, LP:lakshman@hku.hk | en_HK |
dc.identifier.authority | Samaranayake, LP=rp00023 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1034/j.1601-0825.2002.01818.x | en_HK |
dc.identifier.pmid | 12206401 | - |
dc.identifier.scopus | eid_2-s2.0-0036021296 | en_HK |
dc.identifier.hkuros | 67455 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0036021296&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 8 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 199 | en_HK |
dc.identifier.epage | 206 | en_HK |
dc.identifier.isi | WOS:000176662500005 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Anil, S=7006640037 | en_HK |
dc.identifier.scopusauthorid | Samaranayake, LP=7102761002 | en_HK |
dc.identifier.issnl | 1354-523X | - |